Co-Authors
This is a "connection" page, showing publications co-authored by Fabrizio Conti and Fulvia Ceccarelli.
Connection Strength
3.032
-
SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case. Lupus. 2021 09; 30(10):1698-1699.
Score: 0.954
-
Systemic Lupus Erythematosus before and after COVID-19 Lockdown: How the Perception of Disease Changes through the Lenses of Narrative Medicine. Healthcare (Basel). 2021 Jun 12; 9(6).
Score: 0.950
-
Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli et al. Ann Rheum Dis. 2021 10; 80(10):e169.
Score: 0.236
-
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists. Ann Rheum Dis. 2021 07; 80(7):953-954.
Score: 0.233
-
Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis. Ann Rheum Dis. 2021 01; 80(1):e9.
Score: 0.220
-
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al. Ann Rheum Dis. 2021 02; 80(2):e20.
Score: 0.220
-
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic. Ann Rheum Dis. 2020 05; 79(5):666-667.
Score: 0.219